Novel 3'-C/N-substituted 2',3'-beta-D-dideoxynucleosides as potential chemotherapeutic agents .1. Thymidine derivatives: Synthesis, structure, and broad spectrum antiviral properties

被引:19
作者
Fedorov, II
Kazmina, EM
Gurskaya, GV
Jasko, MV
Zavodnic, VE
Balzarini, J
DeClercq, E
Faraj, A
Sommadossi, JP
Imbach, JL
Gosselin, G
机构
[1] UNIV MONTPELLIER 2, CHIM BIOORGAN LAB, UMR CNRS 5625, F-34095 MONTPELLIER 05, FRANCE
[2] MOSCOW MED SECHENOV ACAD, MOSCOW 119881, RUSSIA
[3] VA ENGELHARDT MOL BIOL INST, MOSCOW 117984, RUSSIA
[4] LY KARPOV PHYS CHEM RES INST, MOSCOW 103064, RUSSIA
[5] CATHOLIC UNIV LEUVEN, REGA INST MED RES, B-3000 LOUVAIN, BELGIUM
[6] UNIV ALABAMA, DEPT PHARMACOL, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1021/jm960500w
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A synthetic scheme for the 3'-oxime derivatives 3E, 5E, 5Z, 7E and 7Z of 1-(2,3-dideoxy-beta-D-glycero-pentofuranosyl)thymine and for 1-(2,3-dideoxy-3-nitro-beta-D-erythro-pentofuranosyl)-thymine (10) has been developed starting from appropriately 5'-protected 3'-ketothymidine. X-ray analysis showed that 3'-N-hydroxyimino 3E and 3'-N-methoxyimino 5Z derivatives have close molecular conformations: anti about the N1-C1' bond, and gauche(+) about the C4'-C5' exocyclic bond. Their sugar conformations are C1'-exo-O4'-endo and C1'-exo-C2'-endo, respectively. The antiviral assays in cell cultures demonstrated that 3'-N-hydroxyimino 3E and 3'-N-acetoxyimino 7E + 7Z derivatives are endowed with significant activity against human immunodeficiency virus (HIV) with EC(50) values ranging between 0.02 and 0.40 mu g/mL for both HIV-1 and HIV-2. The other compounds 5E + 5Z and 10 were at least 2 orders of magnitude less active. The 3'-N-hydroxyimino derivative 3E also shows promising activity against hepatitis B virus (HBV) (EC(50) = 0.25 mu g/mL) and against herpes simplex virus type 1 (HSV-1) and HSV-2.
引用
收藏
页码:486 / 494
页数:9
相关论文
共 31 条
[1]   SOLUTION AND SOLID-STATE STRUCTURE OF 2',5'-BIS-(O-TRITYL)-3'-OXIMINOURIDINE [J].
AGBACK, P ;
PAPCHIKHIN, A ;
NEIDLE, S ;
CHATTOPADHYAYA, J .
NUCLEOSIDES & NUCLEOTIDES, 1993, 12 (06) :605-614
[2]   9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE (PMEA) EFFECTIVELY INHIBITS RETROVIRUS REPLICATION INVITRO AND SIMIAN IMMUNODEFICIENCY VIRUS-INFECTION IN RHESUS-MONKEYS [J].
BALZARINI, J ;
NAESENS, L ;
SLACHMUYLDERS, J ;
NIPHUIS, H ;
ROSENBERG, I ;
HOLY, A ;
SCHELLEKENS, H ;
DECLERCQ, E .
AIDS, 1991, 5 (01) :21-28
[3]   DETERMINATION OF GLYCOSIDIC BOND CONFORMATIONS OF PYRIMIDINE NUCLEOSIDES AND NUCLEOTIDES USING VICINAL CARBON PROTON COUPLING-CONSTANTS [J].
DAVIES, DB ;
RAJANI, P ;
SADIKOT, H .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1985, (02) :279-285
[4]   ANTIVIRAL THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS [J].
DECLERCQ, E .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (02) :200-239
[5]   TOWARD IMPROVED ANTI-HIV CHEMOTHERAPY - THERAPEUTIC STRATEGIES FOR INTERVENTION WITH HIV-INFECTIONS [J].
DECLERCQ, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2491-2517
[6]   COMPARATIVE EFFICACY OF ANTIHERPES DRUGS AGAINST DIFFERENT STRAINS OF HERPES-SIMPLEX VIRUS [J].
DECLERCQ, E ;
DESCAMPS, J ;
VERHELST, G ;
WALKER, RT ;
JONES, AS ;
TORRENCE, PF ;
SHUGAR, D .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (05) :563-574
[7]   A NOVEL SELECTIVE BROAD-SPECTRUM ANTI-DNA VIRUS AGENT [J].
DECLERCQ, E ;
HOLY, A ;
ROSENBERG, I ;
SAKUMA, T ;
BALZARINI, J ;
MAUDGAL, PC .
NATURE, 1986, 323 (6087) :464-467
[8]  
DECLERCQ E, 1981, MOL PHARMACOL, V19, P321
[9]   3'-C-BRANCHED 2'-DEOXY-5-METHYLURIDINES - SYNTHESIS, ENZYME-INHIBITION, AND ANTIVIRAL PROPERTIES [J].
FEDOROV, II ;
KAZMINA, EM ;
NOVICOV, NA ;
GURSKAYA, GV ;
BOCHKAREV, AV ;
JASKO, MV ;
VICTOROVA, LS ;
KUKHANOVA, MK ;
BALZARINI, J ;
DECLERCQ, E ;
KRAYEVSKY, AA .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (24) :4567-4575
[10]   AN IMPROVED SYNTHESIS OF 3'-KETO-5'-O-TRITYLTHYMIDINE [J].
FROEHLICH, ML ;
SWARTLING, DJ ;
LIND, RE ;
MOTT, AW ;
BERGSTROM, DE .
NUCLEOSIDES & NUCLEOTIDES, 1989, 8 (08) :1529-1535